These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34339083)

  • 1. A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.
    Chang KM; Berlinrut I; Wallach FR
    Transpl Infect Dis; 2021 Oct; 23(5):e13710. PubMed ID: 34339083
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.
    Tsalouchos A; Rossolini GM; Maggi L; Mazzoni A; Annunziato F; Dattolo PC
    Transpl Infect Dis; 2021 Aug; 23(4):e13649. PubMed ID: 34032340
    [No Abstract]   [Full Text] [Related]  

  • 3. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 4. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients.
    Basic-Jukic N; Ivo J
    Transpl Infect Dis; 2021 Aug; 23(4):e13628. PubMed ID: 33915005
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Cellular Rejection in A Kidney Transplant Recipient Following Vaccination with Inactivated SARS-CoV-2 Vaccine.
    Missoum S; Lahmar M; Khellaf G
    Iran J Kidney Dis; 2022 Jul; 16(4):269-271. PubMed ID: 35962643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review.
    Akyol M; Çevik E; Ucku D; Tanrıöver C; Afşar B; Kanbay A; Covic A; Ortiz A; Basile C; Kanbay M
    Tuberk Toraks; 2021 Dec; 69(4):547-560. PubMed ID: 34957748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
    Dumortier J
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
    Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
    Transpl Int; 2021; 35():10026. PubMed ID: 35185359
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients.
    Bertrand D; Candon S
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):3-5. PubMed ID: 34937770
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Laurent C; Etienne I; Lemoine M; Lebourg L; Hanoy M; Le Roy F; Nezam D; Farce F; Plantier JC; Boyer O; Guerrot D; Candon S
    Kidney Int; 2021 Dec; 100(6):1337-1340. PubMed ID: 34619232
    [No Abstract]   [Full Text] [Related]  

  • 17. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
    Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K;
    Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to two doses of inactivated SARS-CoV-2 vaccine (CoronaVac) in kidney transplant recipients.
    Eren Sadioğlu R; Demir E; Evren E; Aktar M; Şafak S; Artan AS; Meşe S; Ağaçfidan A; Çınar G; Önel M; Karahan ZC; Şengül Ş; Keven K; Türkmen A
    Transpl Infect Dis; 2021 Dec; 23(6):e13740. PubMed ID: 34606134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 despite full COVID-19 vaccination.
    Mungmunpuntipantip R; Wiwanitkit V
    Transpl Infect Dis; 2021 Oct; 23(5):e13712. PubMed ID: 34382709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.